McLoed, A.G.* ; Sherrill, T.P.* ; Cheng, D.S.* ; Han, W.* ; Saxon, J.A.* ; Gleaves, L.A.* ; Wu, P.* ; Polosukhin, V.V.* ; Karin, M.* ; Yull, F.E.* ; Stathopoulos, G.T. ; Georgoulias, V.* ; Zaynagetdinov, R.* ; Blackwell, T.S.*
Neutrophil-derived IL-1β impairs the efficacy of NF-κB inhibitors against lung cancer.
Cell Rep. 16, 120-132 (2016)
Although epithelial NF-κB signaling is important for lung carcinogenesis, NF-κB inhibitors are ineffective for cancer treatment. To explain this paradox, we studied mice with genetic deletion of IKKβ in myeloid cells and found enhanced tumorigenesis in Kras(G12D) and urethane models of lung cancer. Myeloid-specific inhibition of NF-κB augmented pro-IL-1β processing by cathepsin G in neutrophils, leading to increased IL-1β and enhanced epithelial cell proliferation. Combined treatment with bortezomib, a proteasome inhibitor that blocks NF-κB activation, and IL-1 receptor antagonist reduced tumor formation and growth in vivo. In lung cancer patients, plasma IL-1β levels correlated with poor prognosis, and IL-1β increased following bortezomib treatment. Together, our studies elucidate an important role for neutrophils and IL-1β in lung carcinogenesis and resistance to NF-κB inhibitors.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Malignant Pleural Effusion; Ikk-beta; Mouse Model; Activation; Carcinogenesis; Tumorigenesis; Inflammation; Cells; Adenocarcinoma; Proliferation
Keywords plus
Language
english
Publication Year
2016
Prepublished in Year
HGF-reported in Year
2016
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 16,
Issue: 1,
Pages: 120-132
Article Number: ,
Supplement: ,
Series
Publisher
Cell Press
Publishing Place
Cambridge
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Lung Research
PSP Element(s)
G-501600-003
Grants
Copyright
Erfassungsdatum
2016-06-27